Tag | Content |
---|
EnhancerAtlas ID | HS109-08837 | Organism | Homo sapiens | Tissue/cell | Kasumi-1 | Coordinate | chr17:437170-438380 | | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_30726 | chr17:436289-439635 | Fetal_Muscle | SE_37538 | chr17:436801-438552 | HSMMtube |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr17 | 437481 | 437600 | chr17 | 437600 | 437875 |
| | Number: 1 | ID | Chromosome | Start | End |
GH17I000533 | chr17 | 436840 | 439401 |
| Enhancer Sequence | CTGGGTTCAA GCAATTCTGG TGCCTCAGCC TCCTGAGTAG CTGGGACTAC AGGCACGCAC 60 CAGCATACCC AGCTAATTTT TGTATTTTTA GTAGAGATAG GGTTTCACCA TGTTGGCCAG 120 GCTGGTCTCG AACTCCTGGC CTCAAGTGAT CCTCTTGCCT CGGCCCCACA AAGCGCTGGG 180 ATGACAGGCG TGAGCCACCG CGCCCAGCCA CCTACCACTT TTTGAATGTC AGCTTGGTAT 240 CAGCACTTTA CCAGGAAGTT AATATGTGAC TTCTCATTTT ATCTTCCCAA CCACTATTAT 300 GAGATTTGTC TCATTATCTC CTTGATTGAA GGGAGGAGGA TCAGCTCAGT GGATGAGGGA 360 AGTTGCTTGT GGTTCAACTG CAGTTTCAAC CAGGCTGTGG ATTTTGATGT CTCAACAGGA 420 AAGGCTGCTA TTGCTTAAGA CAGCAAACGA GGTAAAAGGA AACATCTATG GTTTTGCAGG 480 GGTGGGGTAG AAAGGAAGCT GAGGGAGAGG AAACTGGAGT CCGGAGATCG GATCTGGAGG 540 TGGCTTGTGA TCAGGAAGGA GAGTAAACAA GGGGCTATTT GGAAGGAATT CCTCAGTGCT 600 GGAAACCAGA GCCAGACAAG CAACATGAAA CTGAACTCAT GACCAATGGC AGCTGTGCAC 660 ACAGCGCTTT GTAACCTAAG TTGCTTCACA TTAGAACATG CTCCGGACTG GGCATGGCAG 720 CTCATGCCTA TAATCCCAGC ACTCTGAGAG GCCCAGGCAG GTGGACTGCT TGAGCCCAGG 780 AGTTTGAGAC CAGCCTGGGC AACATGGCAA AATCTCATCT CTACAAAAAA TAGAAAAATG 840 AGCTAGGCCG GGTGGCGAGC GCCTGTAATC CCAGCTATTC AGGAGGCTGA GGTGGGAGAA 900 TCACCTAAGC CCAGGAGATG GGGGCTGCAG TGAGCTGTGG TTGCACCACT GCACTCCAGC 960 CTGGGTAACA GAGTGGGACC CTGTATCAAA AAAAAAAAAA AAAACCTTTG GCTGTGCCCC 1020 TGAACTGGCT CTCTATACTA GTCTACAGGT GGCGATGGGG GGAGTATGAG GACCTGACAC 1080 ACGTCCTGTG GGGAAAAAAC CAAGCAATGT GCTGGGTAAC TGCCAAGGGC TTCTCTGGGC 1140 CATCAGGGCG GTGGTGGCTG CTGCCCTTGA CCAGGGAAGG GTCTCCTCAC AAGCCCACCT 1200 CTGTTAAGCG 1210
|
| |
|
|
|